Generation and characterization of a human iPSC line and gene-corrected isogenic line derived from a patient with a CELF2 gene mutation

Generation and characterization of a human iPSC line and gene-corrected isogenic line derived from a patient with a CELF2 gene mutation

The identification of neurodevelopmental defects in a patient harboring a heterozygous de novo missense variant (NM_006561.4, c.1517G > A, p.Arg506His) within the CELF2 gene. Here, we describe the establishment of a patient-derived induced pluripotent stem cell (iPSC) line, alongside an isogenic...

Full description

Bibliographic Details
Main Authors:	Michelle Hua, Laura Williams, Kaylan Burns, Shiying Liu, James Ellis, A. Micheil Innes, Melissa McPherson, Guang Yang
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506124000424

Similar Items

Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line
by: Benjamin Schmid, et al.
Published: (2019-01-01)

Generation of two human isogenic iPSC lines from fetal dermal fibroblasts
by: Rashmi Tandon, et al.
Published: (2018-12-01)

Generation of two isogenic iPSC lines from a healthy male donor of European ancestry
by: S. Edwards, et al.
Published: (2024-06-01)

Generation of two isogenic iPSC lines with either a heterozygous or a homozygous E280A mutation in the PSEN1 gene
by: Henriette R. Frederiksen, et al.
Published: (2019-03-01)

Generation of gene-corrected isogenic control cell lines from a DYT1 dystonia patient iPSC line carrying a heterozygous GAG mutation in TOR1A gene
by: Masuma Akter, et al.
Published: (2022-07-01)

Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1
by: Carlota Pires, et al.
Published: (2016-09-01)

Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variant
by: Nikita Kozhushko, et al.
Published: (2023-06-01)

Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy
by: Nele Warnecke, et al.
Published: (2021-08-01)

Generation of a gene-corrected isogenic control iPSC line from cystic fibrosis patient-specific iPSCs homozygous for p.Phe508del mutation mediated by TALENs and ssODN
by: Sylvia Merkert, et al.
Published: (2017-08-01)

Generation of a gene-corrected human isogenic line (UAMi006-A) from propionic acidemia patient iPSC with an homozygous mutation in the PCCB gene using CRISPR/Cas9 technology
by: Alejandro Fulgencio-Covián, et al.
Published: (2020-12-01)

Generation of two TMEM16A knockout iPSC clones each from a healthy human iPSC line, from a Cystic Fibrosis patient specific line with p.Phe508del mutation and from the gene corrected iPSC line
by: Mark-Christian Jaboreck, et al.
Published: (2022-10-01)

Generation of an induced pluripotent stem cell line from an Alström Syndrome patient with ALMS1 mutation (c.3902C > A, c.6436C > T) and a gene correction isogenic iPSC line
by: Xiaoli Ji, et al.
Published: (2020-12-01)

Mitochondrial Alterations by PARKIN in Dopaminergic Neurons Using PARK2 Patient-Specific and PARK2 Knockout Isogenic iPSC Lines
by: Atossa Shaltouki, et al.
Published: (2015-05-01)

Generating an iPSC line (with isogenic control) from the PBMCs of an ACTA1 (p.Gly148Asp) nemaline myopathy patient
by: Peter J. Houweling, et al.
Published: (2021-07-01)

Generation of an iPSC line (SCTCi015-A) and isogenic control line (SCTCi015-A-1) from an age-related macular degeneration patient carrying the variant c.355G>A in the CFI gene
by: Sarah de Jong, et al.
Published: (2022-07-01)

Generation of an iPSC line (SCTCi014-A) and isogenic control line (SCTCi014-A-1) from an age-related macular degeneration patient carrying the variant c.355G>A in the CFI gene
by: Sarah de Jong, et al.
Published: (2022-07-01)

Generation of a gene-corrected isogenic iPSC cell line from an X-linked retinoschisis patient with a hemizygous mutation c.304C > T (p.R102W) in RS1 gene
by: Shengru Mao, et al.
Published: (2023-12-01)

Isogenic FUS-eGFP iPSC Reporter Lines Enable Quantification of FUS Stress Granule Pathology that Is Rescued by Drugs Inducing Autophagy
by: Lara Marrone, et al.
Published: (2018-02-01)

Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9
by: Chun-Lin Liu, et al.
Published: (2020-05-01)

Corrigendum to “Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line” [Stem Cell Res. 34/1873–5061 (2019) 101349–55]
by: Benjamin Schmid, et al.
Published: (2020-10-01)

Generation of iPSC line from a Parkinson patient with PARK7 mutation and CRISPR-edited Gibco human episomal iPSC line to mimic PARK7 mutation
by: Melissa Conti Mazza, et al.
Published: (2021-08-01)

Modeling native and seeded Synuclein aggregation and related cellular dysfunctions in dopaminergic neurons derived by a new set of isogenic iPSC lines with SNCA multiplications
by: Angelo Iannielli, et al.
Published: (2022-10-01)

Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model.
by: Gene Ananiev, et al.
Published: (2011-01-01)

Generation of an isogenic gene-corrected iPSC line (PUMCHi001-A-1) from a familial partial lipodystrophy type 2 (FPLD2) patient with a heterozygous R349W mutation in the LMNA gene
by: Cheng Xiao, et al.
Published: (2020-04-01)

Generation of a gene corrected human isogenic iPSC line (CPGHi002-A-1) from a DDOD patient with heterozygous c.1516 C>T mutation in the ATP6V1B2 gene
by: Xue Gao, et al.
Published: (2021-05-01)

Generation of a CHIP isogenic human iPSC-derived cortical neuron model for functional proteomics
by: Catarina Dias, et al.
Published: (2022-06-01)

Human iPSC lines from a Christianson syndrome patient with NHE6 W523X mutation, a biologically-related control, and CRISPR/Cas9 gene-corrected isogenic controls
by: Li Ma, et al.
Published: (2021-07-01)

Modeling mutation-specific arrhythmogenic phenotypes in isogenic human iPSC-derived cardiac tissues
by: Thomas L. Maurissen, et al.
Published: (2024-01-01)

Brain microvascular endothelial cell dysfunction in an isogenic juvenile iPSC model of Huntington’s disease
by: Raleigh M. Linville, et al.
Published: (2022-06-01)

Generation of an isogenic gene-corrected iPSC line (OGHFUi001-A-1) from a type 1 early infantile epileptic encephalopathy (EIEE1) patient with a hemizygous R330L mutation in the ARX gene
by: Xiaohui Gong, et al.
Published: (2022-04-01)

Generation of iPSC line iPSC-FH2.1 in hypoxic conditions from human foreskin fibroblasts
by: María Questa, et al.
Published: (2016-03-01)

Generation of a human Tropomyosin 1 knockout iPSC line
by: Madison B. Wilken, et al.
Published: (2023-09-01)

Generation of a human iPSC line by mRNA reprogramming
by: Ana Artero Castro, et al.
Published: (2018-04-01)

Rapid Generation of Human Genetic Loss-of-Function iPSC Lines by Simultaneous Reprogramming and Gene Editing
by: Andrew M. Tidball, et al.
Published: (2017-09-01)

Derivation of iPSC line UMi029-A bearing a hearing-loss associated variant in the SMPX gene
by: Derek M. Dykxhoorn, et al.
Published: (2021-07-01)

Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome
by: Glen Lester Sequiera, et al.
Published: (2021-03-01)

Generation of three human iPSC lines from patients with Huntington’s disease with different CAG lengths and human control iPSC line from a healthy donor
by: Ewelina Latoszek, et al.
Published: (2022-10-01)

Generation of iPSC line from a Joubert syndrome patient with compound heterozygous mutations in CPLANE1 gene
by: Mazzotta C., et al.
Published: (2024-02-01)

Establishment of two iPSC lines from healthy donor with heterozygous mutation in the SLC26A4 gene
by: SiJun Li, et al.
Published: (2022-10-01)

Generation of a homozygous CRISPR/Cas9-mediated knockout human iPSC line for PTCH1 gene
by: Bailing Zu, et al.
Published: (2021-10-01)